동화약품
5,400KRWMarket close of 10/21 (Wed)
Down -1.28%-70KRWMarket close of 10/21 (Wed)
- Open
- 5,470
- High
- 5,530
- Low
- 5,330
- Day range
- Day range low 5,330 high 5,530, open 5,470, close 5,400, previous close 5,470
- Volume
- 15×10K shares
- 820.22 million KRW 0.27× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
40%1-year close range 4,550 to 6,670 won, 40% up from the low
40% of the way up from the lowest close in 1 year (252 sessions) · -19.0% from the high
Usual range
Nothing unusual in the 4 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range-1.28%-1.28%, 0.9× the usual (20-session average ±1.47%)That day -1.28% · usual ±1.47% · large-move threshold ±3.0%
The other 3 are within the usual range
- Trading value0.3×usual range
- EarningsOperating income, 8 quarters
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue130.6B KRW
- vs. year ago
- +3.9%
- vs. prior quarter
- +5.6%
- Operating income11.2B KRW
- vs. year ago
- +394.8%
- vs. prior quarter
- Turned profitable
- Operating margin8.6%
- vs. year ago
- +6.8 pp
- vs. prior quarter
- +11.8 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-06-17Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.